In individuals with AD and asymptomatic individuals with high risk of dementia, the glucose uptake rate has been shown to be reduced in CECs (Herholz, 2010); one possible explanation is the function of GLUT-1 is impaired, which has been demonstrated in patients with AD (Mooradian et al., 1997). This evidence concerns the gene SLC2A1 and Alzheimer disease.